Merck KGaA (MKKGY) News Today $28.72 +0.15 (+0.53%) (As of 12/20/2024 05:55 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartDividendEarningsHeadlinesShort Interest All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Merck reaches weight-loss drug deal worth up to $2 billion with China-based HansohDecember 18 at 8:38 PM | msn.comMerck KGaA (OTCMKTS:MKKGY) Sets New 1-Year Low - Here's WhyMerck KGaA (OTCMKTS:MKKGY) Hits New 12-Month Low - Here's WhyDecember 18 at 6:48 PM | marketbeat.comMerck Makes Another Play for Lucrative Obesity-Drug MarketDecember 18 at 3:36 PM | wsj.comMerck, Hansoh Pharma in Obesity Pill License Potentially Worth More Than $2 BillionDecember 18 at 9:06 AM | marketwatch.comMerck Enters Into Exclusive Global License Agreement With Hansoh Pharma For HS-10535December 18 at 9:06 AM | markets.businessinsider.comMerck in Pact for Chinese Obesity Drug in Nearly $2 Billion DealDecember 18 at 9:06 AM | msn.comMerck & Company’s Strategic Pivots and Growth Potential: A Buy Rating JustificationDecember 18 at 4:05 AM | markets.businessinsider.comMerck KGaA (OTCMKTS:MKKGY) Short Interest UpdateMerck KGaA (OTCMKTS:MKKGY - Get Free Report) was the recipient of a large decrease in short interest in November. As of November 30th, there was short interest totalling 1,600 shares, a decrease of 97.2% from the November 15th total of 56,900 shares. Based on an average trading volume of 245,500 shares, the short-interest ratio is currently 0.0 days.December 13, 2024 | marketbeat.comDZ BANK AG Sticks to Its Buy Rating for Merck KGaA (0O14)December 3, 2024 | markets.businessinsider.comMerck reports ‘positive’ results from Phase 3 ZENITH trial evaluating WinrevairNovember 25, 2024 | markets.businessinsider.comKepler Capital Sticks to Its Buy Rating for Merck KGaA (0O14)November 16, 2024 | markets.businessinsider.comMerck KGaA Third Quarter 2024 Earnings: Misses ExpectationsNovember 16, 2024 | finance.yahoo.comMerck initiated with a Peer Perform at Wolfe ResearchNovember 14, 2024 | markets.businessinsider.comMerck Snags Chinese Cancer Drug in Deal Worth Up to $3.3 BillionNovember 14, 2024 | msn.comMerck signs up to $3.3 billion cancer drug deal with China-based LaNovaNovember 14, 2024 | msn.comMerck KGaA stock falls on weak Q3, soft outlookNovember 14, 2024 | investing.comMerck KGaA, Darmstadt, Germany and Intel Launch Academic Research Program in Europe for More Sustainable Semiconductor ManufacturingNovember 7, 2024 | financialpost.comMerck's Unity-SC acquisition bolsters optoelectronic capabilityNovember 4, 2024 | msn.comKepler Capital Reaffirms Their Buy Rating on Merck KGaA (0O14)November 3, 2024 | markets.businessinsider.comMerck Tops Earnings Estimates but Lowers Full-Year GuidanceNovember 2, 2024 | msn.comMerck price target lowered to $110 from $125 at Wells FargoNovember 1, 2024 | markets.businessinsider.comMerck Narrows Sales Outlook With Gardasil Lagging in ChinaNovember 1, 2024 | msn.comMerck cuts FY24 adjusted EPS view to $7.72-$7.77 from $7.94-$8.04November 1, 2024 | markets.businessinsider.comMerck Q3 Earnings Review: Solid Financials May Be Undermined By New Keytruda ThreatOctober 25, 2024 | seekingalpha.comMerck price target lowered to $130 from $140 at CitiOctober 25, 2024 | markets.businessinsider.comMerck: EC approves two new indications for KeytrudaOctober 25, 2024 | markets.businessinsider.comMerck partners with Riley to provide free period products to four East Cork secondary schoolsOctober 24, 2024 | msn.comMerck buys cancer therapy developer Modifi Biosciences for up to $1.3 billionOctober 24, 2024 | msn.comMerck Keytruda cleared in EU for two new indications in gynecologic cancersOctober 24, 2024 | seekingalpha.comMerck antibody reduces RSV-related disease, hospitalizations in trialOctober 18, 2024 | finance.yahoo.comAI is driving semiconductor industry, says CEO Electronics at Merck KgaAOctober 18, 2024 | msn.comMerck's Posts More Positive Clesrovimab RSV Candidate Study DataOctober 17, 2024 | marketwatch.comGerman science and tech giant Merck confirms full-year guidanceOctober 17, 2024 | msn.comMerck lowers mid-term healthcare outlook after recent drug failuresOctober 17, 2024 | reuters.comMerck KGaA Shares Jump on Expectations of AI BoostOctober 17, 2024 | wsj.comMerck KGaA Trims Health Care And Life Sciences Targets, Eyes M&AOctober 17, 2024 | bloomberg.comMerck KGaA Cuts Medium-Term Healthcare, Life-Science Outlook but Lifts Electronics GuidanceOctober 17, 2024 | msn.comMerck Korea opens chip R&D center in GyeonggiOctober 10, 2024 | msn.comMerck opens spin-on-dielectric application lab for next-gen chipsOctober 10, 2024 | msn.comMerck unveils €290m biosafety testing facility in Maryland, USOctober 10, 2024 | finance.yahoo.comCerevance Achieves Second Milestone in Research Collaboration with MerckOctober 8, 2024 | finance.yahoo.comMerck immune from antitrust claim that it misled FDA about mumps vaccine, court rulesOctober 7, 2024 | reuters.comMerck: Murky Is A Better Description - Strong Sell (Technical Analysis)October 7, 2024 | seekingalpha.comEvaxion Biotech Gains Buy Rating Amid Merck Collaboration and AI-Driven Vaccine Development ProspectsSeptember 27, 2024 | markets.businessinsider.comMerck KGaA's (ETR:MRK) earnings growth rate lags the 11% CAGR delivered to shareholdersSeptember 27, 2024 | finance.yahoo.comMerck Reports Approval In Japan For KEYTRUDA Regimen For Certain Patients With NSCLCSeptember 26, 2024 | markets.businessinsider.comMerck Announces Expansion Of Nobivac NXT Platform For Treatment Of Feline Leukemia VirusSeptember 24, 2024 | markets.businessinsider.comMerck Gets European Panel Backing for Keytruda in Two Gynecologic CancersSeptember 20, 2024 | marketwatch.comMerck's Keytruda Secures First FDA-Approval For Rare Form Aggressive CancerSeptember 18, 2024 | benzinga.comMerck Gets First FDA Approval of Keytruda in Malignant Pleural MesotheliomaSeptember 18, 2024 | marketwatch.com Get Merck KGaA News Delivered to You Automatically Sign up to receive the latest news and ratings for MKKGY and its competitors with MarketBeat's FREE daily newsletter. Email Address Why I'm telling friends to avoid gold stocks (Ad)Back in November, gold made a tiny move of 1.6%. But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period. It's all about catching what I call "Acceleration Cycles." And if you’d like to get your hands on this, here you go, the complete breakdown. MKKGY Media Mentions By Week MKKGY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MKKGY News Sentiment▼0.200.61▲Average Medical News Sentiment MKKGY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MKKGY Articles This Week▼74▲MKKGY Articles Average Week Get Merck KGaA News Delivered to You Automatically Sign up to receive the latest news and ratings for MKKGY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies GSK News Today Takeda Pharmaceutical News Today UCB News Today UCB News Today Alnylam Pharmaceuticals News Today Teva Pharmaceutical Industries News Today Merck KGaA News Today Astellas Pharma News Today BeiGene News Today United Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:MKKGY) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Merck KGaA Please log in to your account or sign up in order to add this asset to your watchlist. Share Merck KGaA With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MKKGY Stock Alerts